Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Neuroma, Acoustic Clinical Trial

Official title:

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03970681
• Other study ID #: 7417
• Status: Recruiting
• Start date: May 29, 2019
• Est. completion date: May 2020

Study information

• Verified date: May 2019
• Source: University Hospital, Strasbourg, France
• Contact: Anne CHARPIOT, MD, PhD
• Phone: 33 3 88 12 76 49
• Email: anne.charpiot[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate the regression characteristics of this Acoustic Neuroma population using volumetric data To study the relationship between regression and clinical characteristics including tinnitus, dizziness, hearing loss, and the intrinsic characteristics of the patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: May 2020
• Est. primary completion date: May 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major subject (=18 years old)

• Subject followed in radiology for the assessment or follow-up of neuroma between January 01, 2013 and June 30, 2018

• Subject who has agreed to the use of his data for the purpose of this research

• Subject presenting an untreated neuroma

Exclusion Criteria:

• Subject having expressed his opposition to participating in the study

• Subject followed for neuroma of other cranial pairs,

• Subject followed in the context of type II neurofibromatosis

• Subject with a treated neuroma (radiotherapy or surgery)

Related Conditions & MeSH terms

• Neuroma
• Neuroma, Acoustic

Locations

Country	Name	City	State
France	Service D'Orl Et de Chirurgie Cervico-Faciale	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of tumoral volume using tridimensional reconstruction on MRI, and kinetics of decay		Files analyzed from January 01, 2013 to June 30, 2018